Ardelyx
Nasdaq ARDX · Fremont, CA
Works in Metabolic & endocrine · Renal & urogenital · Women's health
Ardelyx is a clinical trial sponsor based in Fremont, CA, listed as Nasdaq ARDX. It has 2 active clinical trials with 842 planned participants, in Metabolic & endocrine, Renal & urogenital and Women's health. Since 2021 it has completed 8 trials and stopped 0 early.
Trial track record · since 2021
Financials · Nasdaq ARDX
Pipeline · 2 active trials
| Stage | Trial | Status |
|---|---|---|
On the market
2 approved drug applications with a product on the market.
Questions about Ardelyx
Ardelyx is lead sponsor of 2 active clinical trials on ClinicalTrials.gov, with 842 planned participants, in Metabolic & endocrine, Renal & urogenital, Women's health. Since 2021 it has completed 8 trials and stopped 0 early.
Ardelyx is based in Fremont, CA and is listed as Nasdaq ARDX. The address is the one on its SEC filings, which name the establishment or the registrant, not always the group's head office.
From public sources only: ClinicalTrials.gov for trials, FDA's Data Dashboard, warning-letter listing and enforcement reports for the FDA record, and SEC filings for financials. Approve Suite is not affiliated with Ardelyx; every record links to the source, and nothing here is advice.
See the rest of this profile
A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.
Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-22.
Approve Suite is not affiliated with Ardelyx.
See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.